메뉴 건너뛰기




Volumn 22, Issue 46, 2016, Pages 10103-10117

Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective

Author keywords

Azathioprine; Crohn's disease; Inflammatory bowel disease; Mercaptopurine; Thiopurines; Ulcerative colitis

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ADALIMUMAB; ALLOPURINOL; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PLACEBO; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY; GASTROINTESTINAL AGENT; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR;

EID: 85006373113     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i46.10103     Document Type: Review
Times cited : (40)

References (127)
  • 1
    • 0013824754 scopus 로고
    • Treatment of rheumatoid arthritis with immunosuppressive drugs. II. Immunological study
    • [PMID: 5837147]
    • Brocteur J, Moens C. Treatment of rheumatoid arthritis with immunosuppressive drugs. II. Immunological study. Acta Rheumatol Scand 1965; 11: 221-230 [PMID: 5837147]
    • (1965) Acta Rheumatol Scand , vol.11 , pp. 221-230
    • Brocteur, J.1    Moens, C.2
  • 2
    • 84873020600 scopus 로고    scopus 로고
    • Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
    • PMID: 22972046
    • Timmer A, McDonald JW, Tsoulis D.J., Macdonald JK. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2012; (9): CD000478 [PMID: 22972046 DOI: 10.1002/14651858.CD000478. pub3]
    • (2012) Cochrane Database Syst Rev , Issue.9
    • Timmer, A.1    McDonald, J.W.2    Tsoulis, D.J.3    Macdonald, J.K.4
  • 3
    • 84896723109 scopus 로고    scopus 로고
    • Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: A meta-analysis
    • PMID: 24312308
    • Gong J, Zhu L, Guo Z., Li Y, Zhu W, Li N., Li J. Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis. PLoS One 2013; 8: e81487 [PMID: 24312308 DOI: 10.1371/journal.pone.0081487]
    • (2013) PLoS One , vol.8
    • Gong, J.1    Zhu, L.2    Guo, Z.3    Li, Y.4    Zhu, W.5    Li, N.6    Li, J.7
  • 4
    • 84908245513 scopus 로고    scopus 로고
    • Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: A meta-analysis
    • e1 PMID: 24907505
    • Jess T, Lopez A, Andersson M., Beaugerie L, Peyrin-Biroulet L. Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis. Clin Gastroenterol Hepatol 2014; 12: 1793-1800.e1 [PMID: 24907505 DOI: 10.1016/j. cgh.2014.05.019]
    • (2014) Clin Gastroenterol Hepatol , vol.12 , pp. 1793-1800
    • Jess, T.1    Lopez, A.2    Andersson, M.3    Beaugerie, L.4    Peyrin-Biroulet, L.5
  • 5
    • 84907222744 scopus 로고    scopus 로고
    • Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease
    • PMID: 25081347
    • Gordon M, Taylor K, Akobeng A.K., Thomas AG. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database Syst Rev 2014; 8: CD010233 [PMID: 25081347 DOI: 10.1002/14651858.CD010233. pub2]
    • (2014) Cochrane Database Syst Rev , vol.8
    • Gordon, M.1    Taylor, K.2    Akobeng, A.K.3    Thomas, A.G.4
  • 6
    • 84979863815 scopus 로고    scopus 로고
    • Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
    • PMID: 26517527
    • Chande N, Patton PH, Tsoulis D.J., Thomas BS, MacDonald JK. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2015; 10: CD000067 [PMID: 26517527 DOI: 10.1002/14651858.CD000067.pub3]
    • (2015) Cochrane Database Syst Rev , vol.10
    • Chande, N.1    Patton, P.H.2    Tsoulis, D.J.3    Thomas, B.S.4    MacDonald, J.K.5
  • 7
    • 0033794050 scopus 로고    scopus 로고
    • Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine
    • [PMID: 11052324]
    • Bowen DG, Selby WS Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine. Dig Dis Sci 2000; 45: 1810-1813 [PMID: 11052324]
    • (2000) Dig Dis Sci , vol.45 , pp. 1810-1813
    • Bowen, D.G.1    Selby, W.S.2
  • 8
    • 0028790186 scopus 로고
    • A controlled double blind study of azathioprine in the management of Crohn's disease
    • [PMID: 8549944]
    • Candy S, Wright J, Gerber M., Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995; 37: 674-678 [PMID: 8549944]
    • (1995) Gut , vol.37 , pp. 674-678
    • Candy, S.1    Wright, J.2    Gerber, M.3    Adams, G.4    Gerig, M.5    Goodman, R.6
  • 9
    • 0033770169 scopus 로고    scopus 로고
    • A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
    • [PMID: 11040176]
    • Markowitz J, Grancher K, Kohn N., Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000; 119: 895-902 [PMID: 11040176]
    • (2000) Gastroenterology , vol.119 , pp. 895-902
    • Markowitz, J.1    Grancher, K.2    Kohn, N.3    Lesser, M.4    Daum, F.5
  • 10
    • 0018888679 scopus 로고
    • Treatment of Crohn's disease with 6-mercaptopurine. A longterm, randomized, double-blind study
    • PMID: 6102739
    • Present DH, Korelitz BI, Wisch N, Glass J.L., Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. A longterm, randomized, double-blind study. N Engl J Med 1980; 302: 981-987 [PMID: 6102739 DOI: 10.1056/NEJM198005013021801]
    • (1980) N Engl J Med , vol.302 , pp. 981-987
    • Present, D.H.1    Korelitz, B.I.2    Wisch, N.3    Glass, J.L.4    Sachar, D.B.5    Pasternack, B.S.6
  • 11
    • 0016171750 scopus 로고
    • Treatment of Crohn's disease with azathioprine: A controlled evaluation
    • [PMID: 4597093]
    • Klein M, Binder HJ, Mitchell M, Aaronson R., Spiro H. Treatment of Crohn's disease with azathioprine: a controlled evaluation. Gastroenterology 1974; 66: 916-922 [PMID: 4597093]
    • (1974) Gastroenterology , vol.66 , pp. 916-922
    • Klein, M.1    Binder, H.J.2    Mitchell, M.3    Aaronson, R.4    Spiro, H.5
  • 12
    • 0015220432 scopus 로고
    • Controlled trial of azathioprine in Crohn's disease
    • [PMID: 4143532]
    • Rhodes J, Bainton D, Beck P., Campbell H. Controlled trial of azathioprine in Crohn's disease. Lancet 1971; 2: 1273-1276 [PMID: 4143532]
    • (1971) Lancet , vol.2 , pp. 1273-1276
    • Rhodes, J.1    Bainton, D.2    Beck, P.3    Campbell, H.4
  • 14
    • 0015246251 scopus 로고
    • Controlled trial of azathioprine in Crohn's disease
    • [PMID: 4107900]
    • Willoughby JM, Beckett J, Kumar P.J., Dawson AM. Controlled trial of azathioprine in Crohn's disease. Lancet 1971; 2: 944-947 [PMID: 4107900]
    • (1971) Lancet , vol.2 , pp. 944-947
    • Willoughby, J.M.1    Beckett, J.2    Kumar, P.J.3    Dawson, A.M.4
  • 16
    • 0033679444 scopus 로고    scopus 로고
    • 6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease
    • [PMID: 11111780]
    • Maté-Jiménez J, Hermida C, Cantero-Perona J, Moreno-Otero R. 6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease. Eur J Gastroenterol Hepatol 2000; 12: 1227-1233 [PMID: 11111780]
    • (2000) Eur J Gastroenterol Hepatol , vol.12 , pp. 1227-1233
    • Maté-Jiménez, J.1    Hermida, C.2    Cantero-Perona, J.3    Moreno-Otero, R.4
  • 17
    • 1542603602 scopus 로고    scopus 로고
    • Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: A randomised, investigator-blind study
    • [PMID: 14563183]
    • Ardizzone S, Bollani S, Manzionna G., Imbesi V, Colombo E, Bianchi Porro G. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Dig Liver Dis 2003; 35: 619-627 [PMID: 14563183]
    • (2003) Dig Liver Dis , vol.35 , pp. 619-627
    • Ardizzone, S.1    Bollani, S.2    Manzionna, G.3    Imbesi, V.4    Colombo, E.5    Bianchi Porro, G.6
  • 21
    • 84881273549 scopus 로고    scopus 로고
    • Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
    • PMID: 23633304
    • Chande N, Tsoulis DJ, MacDonald JK Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2013; 4: CD000545 [PMID: 23633304 DOI: 10.1002/14651858.CD000545.pub4]
    • (2013) Cochrane Database Syst Rev , vol.4
    • Chande, N.1    Tsoulis, D.J.2    MacDonald, J.K.3
  • 22
    • 84898793295 scopus 로고    scopus 로고
    • Gastrointestinal Malignancy and the microbiome
    • e3 PMID: 24406471
    • Abreu MT, Peek RM Gastrointestinal malignancy and the microbiome. Gastroenterology 2014; 146: 1534-1546.e3 [PMID: 24406471 DOI: 10.1053/j.gastro.2014.01.001]
    • (2014) Gastroenterology , vol.146 , pp. 1534-1546
    • Abreu, M.T.1    Peek, R.M.2
  • 23
    • 77950654921 scopus 로고    scopus 로고
    • Small bowel resection rates in Crohn's disease and the indication for surgery over time: Experience from a large tertiary care center
    • PMID: 19798731
    • Lazarev M, Ullman T, Schraut W.H., Kip KE, Saul M, Regueiro M. Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center. Inflamm Bowel Dis 2010; 16: 830-835 [PMID: 19798731 DOI: 10.1002/ibd.21118]
    • (2010) Inflamm Bowel Dis , vol.16 , pp. 830-835
    • Lazarev, M.1    Ullman, T.2    Schraut, W.H.3    Kip, K.E.4    Saul, M.5    Regueiro, M.6
  • 24
    • 66149148366 scopus 로고    scopus 로고
    • Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease
    • PMID: 19009634
    • Mantzaris GJ, Christidou A, Sfakianakis M., Roussos A, Koilakou S, Petraki K., Polyzou P. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease. Inflamm Bowel Dis 2009; 15: 375-382 [PMID: 19009634 DOI: 10.1002/ibd.20777]
    • (2009) Inflamm Bowel Dis , vol.15 , pp. 375-382
    • Mantzaris, G.J.1    Christidou, A.2    Sfakianakis, M.3    Roussos, A.4    Koilakou, S.5    Petraki, K.6    Polyzou, P.7
  • 26
    • 44649193073 scopus 로고    scopus 로고
    • Prevention of postoperative recurrence in Crohn's disease
    • PMID: 17967564
    • Terdiman JP. Prevention of postoperative recurrence in Crohn's disease. Clin Gastroenterol Hepatol 2008; 6: 616-620 [PMID: 17967564 DOI: 10.1016/j.cgh.2007.08.020]
    • (2008) Clin Gastroenterol Hepatol , vol.6 , pp. 616-620
    • Terdiman, J.P.1
  • 27
    • 84887612557 scopus 로고    scopus 로고
    • Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study
    • PMID: 23810678
    • Armuzzi A, Felice C, Papa A., Marzo M, Pugliese D, Andrisani G., Federico F, De Vitis I, Rapaccini GL, Guidi L. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study. J Crohns Colitis 2013; 7: e623-e629 [PMID: 23810678 DOI: 10.1016/j. crohns.2013.04.020]
    • (2013) J Crohns Colitis , vol.7 , pp. e623-e629
    • Armuzzi, A.1    Felice, C.2    Papa, A.3    Marzo, M.4    Pugliese, D.5    Andrisani, G.6    Federico, F.7    De Vitis, I.8    Rapaccini, G.L.9    Guidi, L.10
  • 29
    • 4444353986 scopus 로고    scopus 로고
    • Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial
    • [PMID: 15362027]
    • Hanauer SB, Korelitz BI, Rutgeerts P, Peppercorn M.A., Thisted RA, Cohen RD, Present DH. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004; 127: 723-729 [PMID: 15362027]
    • (2004) Gastroenterology , vol.127 , pp. 723-729
    • Hanauer, S.B.1    Korelitz, B.I.2    Rutgeerts, P.3    Peppercorn, M.A.4    Thisted, R.A.5    Cohen, R.D.6    Present, D.H.7
  • 30
    • 33749189358 scopus 로고    scopus 로고
    • Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease
    • [PMID: 16966711]
    • Herfarth H, Tjaden C, Lukas M., Obermeier F, Dilger K, Müller R, Schölmerich J. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease. Gut 2006; 55: 1525-1526 [PMID: 16966711]
    • (2006) Gut , vol.55 , pp. 1525-1526
    • Herfarth, H.1    Tjaden, C.2    Lukas, M.3    Obermeier, F.4    Dilger, K.5    Müller, R.6    Schölmerich, J.7
  • 31
    • 33847153405 scopus 로고    scopus 로고
    • Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine
    • PMID: 17304143
    • Dilger K, Schaeffeler E, Lukas M., Strauch U, Herfarth H, Müller R, Schwab M. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. Ther Drug Monit 2007; 29: 1-5 [PMID: 17304143 DOI: 10.1097/FTD.0b013e3180312b9a]
    • (2007) Ther Drug Monit , vol.29 , pp. 1-5
    • Dilger, K.1    Schaeffeler, E.2    Lukas, M.3    Strauch, U.4    Herfarth, H.5    Müller, R.6    Schwab, M.7
  • 33
    • 50649125243 scopus 로고    scopus 로고
    • A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease
    • PMID: 18671816
    • Reinisch W, Panés J, Lémann M, Schreiber S., Feagan B, Schmidt S, Sturniolo G.C., Mikhailova T., Alexeeva O, Sanna L, Haas T., Korom S, Mayer H. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease. Am J Gastroenterol 2008; 103: 2284-2292 [PMID: 18671816 DOI: 10.1111/j.1572-0241.2008.02024.x]
    • (2008) Am J Gastroenterol , vol.103 , pp. 2284-2292
    • Reinisch, W.1    Panés, J.2    Lémann, M.3    Schreiber, S.4    Feagan, B.5    Schmidt, S.6    Sturniolo, G.C.7    Mikhailova, T.8    Alexeeva, O.9    Sanna, L.10    Haas, T.11    Korom, S.12    Mayer, H.13
  • 34
    • 84887237442 scopus 로고    scopus 로고
    • Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: A randomized controlled trial
    • PMID: 24019080
    • Savarino E, Bodini G, Dulbecco P., Assandri L, Bruzzone L, Mazza F., Frigo AC, Fazio V, Marabotto E, Savarino V. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. Am J Gastroenterol 2013; 108: 1731-1742 [PMID: 24019080 DOI: 10.1038/ajg.2013.287]
    • (2013) Am J Gastroenterol , vol.108 , pp. 1731-1742
    • Savarino, E.1    Bodini, G.2    Dulbecco, P.3    Assandri, L.4    Bruzzone, L.5    Mazza, F.6    Frigo, A.C.7    Fazio, V.8    Marabotto, E.9    Savarino, V.10
  • 35
    • 53249097726 scopus 로고    scopus 로고
    • Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: A controlled randomized trial
    • PMID: 18727929
    • D'Haens G.R., Vermeire S, Van Assche G, Noman M, Aerden I., Van Olmen G, Rutgeerts P. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology 2008; 135: 1123-1129 [PMID: 18727929 DOI: 10.1053/j.gastro.2008.07.010]
    • (2008) Gastroenterology , vol.135 , pp. 1123-1129
    • D'Haens, G.R.1    Vermeire, S.2    Van Assche, G.3    Noman, M.4    Aerden, I.5    Van Olmen, G.6    Rutgeerts, P.7
  • 36
    • 84906790991 scopus 로고    scopus 로고
    • Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence
    • e1 PMID: 24440221
    • Regueiro M, Kip KE, Baidoo L, Swoger J.M., Schraut W. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence. Clin Gastroenterol Hepatol 2014; 12: 1494-1502.e1 [PMID: 24440221 DOI: 10.1016/j.cgh.2013.12.035]
    • (2014) Clin Gastroenterol Hepatol , vol.12 , pp. 1494-1502
    • Regueiro, M.1    Kip, K.E.2    Baidoo, L.3    Swoger, J.M.4    Schraut, W.5
  • 38
    • 0016607713 scopus 로고
    • Double-blind comparison of the effectiveness of azathioprine and sulfasalazine in idiopathic proctocolitis. Preliminary report
    • [PMID: 235835]
    • Caprilli R, Carratù R, Babbini M. Double-blind comparison of the effectiveness of azathioprine and sulfasalazine in idiopathic proctocolitis. Preliminary report. Am J Dig Dis 1975; 20: 115-120 [PMID: 235835]
    • (1975) Am J Dig Dis , vol.20 , pp. 115-120
    • Caprilli, R.1    Carratù, R.2    Babbini, M.3
  • 39
    • 0016293798 scopus 로고
    • Azathioprine in ulcerative colitis: Final report on controlled therapeutic trial
    • [PMID: 4441827]
    • Jewell DP, Truelove SC Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J 1974; 4: 627-630 [PMID: 4441827]
    • (1974) Br Med J , vol.4 , pp. 627-630
    • Jewell, D.P.1    Truelove, S.C.2
  • 40
    • 0033978036 scopus 로고    scopus 로고
    • Role of azathioprine in severe ulcerative colitis: One-year, placebo-controlled, randomized trial
    • [PMID: 10659481]
    • Sood A, Midha V, Sood N., Kaushal V. Role of azathioprine in severe ulcerative colitis: one-year, placebo-controlled, randomized trial. Indian J Gastroenterol 2000; 19: 14-16 [PMID: 10659481]
    • (2000) Indian J Gastroenterol , vol.19 , pp. 14-16
    • Sood, A.1    Midha, V.2    Sood, N.3    Kaushal, V.4
  • 41
    • 29244457275 scopus 로고    scopus 로고
    • Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
    • PMID: 15972298
    • Ardizzone S, Maconi G, Russo A., Imbesi V, Colombo E, Bianchi Porro G. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006; 55: 47-53 [PMID: 15972298 DOI: 10.1136/gut.2005.068809]
    • (2006) Gut , vol.55 , pp. 47-53
    • Ardizzone, S.1    Maconi, G.2    Russo, A.3    Imbesi, V.4    Colombo, E.5    Bianchi Porro, G.6
  • 42
    • 67649867062 scopus 로고    scopus 로고
    • Meta-analysis: The efficacy of azathioprine and mercaptopurine in ulcerative colitis
    • PMID: 19392869
    • Gisbert JP, Linares PM, McNicholl A.G., Maté J, Gomollón F. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis. Aliment Pharmacol Ther 2009; 30: 126-137 [PMID: 19392869 DOI: 10.1111/j.1365-2036.2009.04023.x]
    • (2009) Aliment Pharmacol Ther , vol.30 , pp. 126-137
    • Gisbert, J.P.1    Linares, P.M.2    McNicholl, A.G.3    Maté, J.4    Gomollón, F.5
  • 43
    • 0036278519 scopus 로고    scopus 로고
    • The efficacy of azathioprine for the treatment of inflammatory bowel disease: A 30 year review
    • [PMID: 11889067]
    • Fraser AG, Orchard TR, Jewell DP The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 2002; 50: 485-489 [PMID: 11889067]
    • (2002) Gut , vol.50 , pp. 485-489
    • Fraser, A.G.1    Orchard, T.R.2    Jewell, D.P.3
  • 44
  • 45
    • 33845482283 scopus 로고    scopus 로고
    • Long term results of use of azathioprine in patients with ulcerative colitis in India
    • PMID: 17143951
    • Sood A, Midha V, Sood N., Bansal M. Long term results of use of azathioprine in patients with ulcerative colitis in India. World J Gastroenterol 2006; 12: 7332-7336 [PMID: 17143951 DOI: 10.3748/wjg.v12.i45.7332]
    • (2006) World J Gastroenterol , vol.12 , pp. 7332-7336
    • Sood, A.1    Midha, V.2    Sood, N.3    Bansal, M.4
  • 46
    • 4644338224 scopus 로고    scopus 로고
    • A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis
    • [PMID: 15297725]
    • Ohno K, Masunaga Y, Ogawa R., Hashiguchi M, Ogata H. [A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis]. Yakugaku Zasshi 2004; 124: 555-560 [PMID: 15297725]
    • (2004) Yakugaku Zasshi , vol.124 , pp. 555-560
    • Ohno, K.1    Masunaga, Y.2    Ogawa, R.3    Hashiguchi, M.4    Ogata, H.5
  • 49
    • 0036255548 scopus 로고    scopus 로고
    • The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis
    • [PMID: 11993510]
    • Sood A, Kaushal V, Midha V., Bhatia KL, Sood N, Malhotra V. The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis. J Gastroenterol 2002; 37: 270-274 [PMID: 11993510]
    • (2002) J Gastroenterol , vol.37 , pp. 270-274
    • Sood, A.1    Kaushal, V.2    Midha, V.3    Bhatia, K.L.4    Sood, N.5    Malhotra, V.6
  • 50
    • 0038374989 scopus 로고    scopus 로고
    • Azathioprine versus sulfasalazine in maintenance of remission in severe ulcerative colitis
    • [PMID: 12839376]
    • Sood A, Midha V, Sood N., Avasthi G. Azathioprine versus sulfasalazine in maintenance of remission in severe ulcerative colitis. Indian J Gastroenterol 2003; 22: 79-81 [PMID: 12839376]
    • (2003) Indian J Gastroenterol , vol.22 , pp. 79-81
    • Sood, A.1    Midha, V.2    Sood, N.3    Avasthi, G.4
  • 51
    • 0031467050 scopus 로고    scopus 로고
    • Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis
    • [PMID: 9412914]
    • Ardizzone S, Molteni P, Imbesi V., Bollani S, Bianchi Porro G. Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis. J Clin Gastroenterol 1997; 25: 330-333 [PMID: 9412914]
    • (1997) J Clin Gastroenterol , vol.25 , pp. 330-333
    • Ardizzone, S.1    Molteni, P.2    Imbesi, V.3    Bollani, S.4    Bianchi Porro, G.5
  • 53
    • 77949522476 scopus 로고    scopus 로고
    • Azathioprine maintains longterm steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis
    • PMID: 19705415
    • Chebli LA, Chaves LD, Pimentel F.F., Guerra DM, Barros RM, Gaburri PD, Zanini A, Chebli JM Azathioprine maintains longterm steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis. Inflamm Bowel Dis 2010; 16: 613-619 [PMID: 19705415 DOI: 10.1002/ibd.21083]
    • (2010) Inflamm Bowel Dis , vol.16 , pp. 613-619
    • Chebli, L.A.1    Chaves, L.D.2    Pimentel, F.F.3    Guerra, D.M.4    Barros, R.M.5    Gaburri, P.D.6    Zanini, A.7    Chebli, J.M.8
  • 54
    • 2342420871 scopus 로고    scopus 로고
    • Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease
    • [PMID: 15118980]
    • Cuffari C, Dassopoulos T, Turnbough L., Thompson RE, Bayless TM. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. Clin Gastroenterol Hepatol 2004; 2: 410-417 [PMID: 15118980]
    • (2004) Clin Gastroenterol Hepatol , vol.2 , pp. 410-417
    • Cuffari, C.1    Dassopoulos, T.2    Turnbough, L.3    Thompson, R.E.4    Bayless, T.M.5
  • 55
    • 0141521863 scopus 로고    scopus 로고
    • Lowdose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis
    • PMID: 14505127
    • Hibi T, Naganuma M, Kitahora T., Kinjyo F, Shimoyama T. Lowdose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. J Gastroenterol 2003; 38: 740-746 [PMID: 14505127 DOI: 10.1007/s00535-003-1139-2]
    • (2003) J Gastroenterol , vol.38 , pp. 740-746
    • Hibi, T.1    Naganuma, M.2    Kitahora, T.3    Kinjyo, F.4    Shimoyama, T.5
  • 57
    • 3142660552 scopus 로고    scopus 로고
    • A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis
    • PMID: 15180735
    • Mantzaris GJ, Sfakianakis M, Archavlis E., Petraki K, Christidou A, Karagiannidis A., Triadaphyllou G. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis. Am J Gastroenterol 2004; 99: 1122-1128 [PMID: 15180735 DOI: 10.1111/j.1572-0241.2004.11481.x]
    • (2004) Am J Gastroenterol , vol.99 , pp. 1122-1128
    • Mantzaris, G.J.1    Sfakianakis, M.2    Archavlis, E.3    Petraki, K.4    Christidou, A.5    Karagiannidis, A.6    Triadaphyllou, G.7
  • 58
    • 0035080617 scopus 로고    scopus 로고
    • The risk of colorectal cancer in ulcerative colitis: A meta-analysis
    • [PMID: 11247898]
    • Eaden JA, Abrams KR, Mayberry JF The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-535 [PMID: 11247898]
    • (2001) Gut , vol.48 , pp. 526-535
    • Eaden, J.A.1    Abrams, K.R.2    Mayberry, J.F.3
  • 60
    • 0025092693 scopus 로고
    • Ulcerative colitis and colorectal cancer. A population-based study
    • PMID: 2215606
    • Ekbom A, Helmick C, Zack M., Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323: 1228-1233 [PMID: 2215606 DOI: 10.1056/ NEJM199011013231802]
    • (1990) N Engl J Med , vol.323 , pp. 1228-1233
    • Ekbom, A.1    Helmick, C.2    Zack, M.3    Adami, H.O.4
  • 61
    • 33644820014 scopus 로고    scopus 로고
    • Increased risk of intestinal cancer in Crohn's disease: A meta-analysis of population-based cohort studies
    • PMID: 16393226
    • Jess T, Gamborg M, Matzen P., Munkholm P, Sørensen TI. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005; 100: 2724-2729 [PMID: 16393226 DOI: 10.1111/j.1572-0241.2005.00287.x]
    • (2005) Am J Gastroenterol , vol.100 , pp. 2724-2729
    • Jess, T.1    Gamborg, M.2    Matzen, P.3    Munkholm, P.4    Sørensen, T.I.5
  • 62
    • 84903362755 scopus 로고    scopus 로고
    • Systematic review with meta-analysis: The declining risk of colorectal cancer in ulcerative colitis
    • PMID: 24612141
    • Castaño-Milla C., Chaparro M, Gisbert JP Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther 2014; 39: 645-659 [PMID: 24612141 DOI: 10.1111/apt.12651]
    • (2014) Aliment Pharmacol Ther , vol.39 , pp. 645-659
    • Castaño-Milla, C.1    Chaparro, M.2    Gisbert, J.P.3
  • 63
    • 0028363515 scopus 로고
    • Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease
    • [PMID: 7910274]
    • Connell WR, Kamm MA, Dickson M, Balkwill A.M., Ritchie JK, Lennard-Jones JE. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994; 343: 1249-1252 [PMID: 7910274]
    • (1994) Lancet , vol.343 , pp. 1249-1252
    • Connell, W.R.1    Kamm, M.A.2    Dickson, M.3    Balkwill, A.M.4    Ritchie, J.K.5    Lennard-Jones, J.E.6
  • 64
    • 34247564971 scopus 로고    scopus 로고
    • 5-aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
    • PMID: 17206695
    • Terdiman JP, Steinbuch M, Blumentals W.A., Ullman TA, Rubin DT. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 367-371 [PMID: 17206695 DOI: 10.1002/ibd.20074]
    • (2007) Inflamm Bowel Dis , vol.13 , pp. 367-371
    • Terdiman, J.P.1    Steinbuch, M.2    Blumentals, W.A.3    Ullman, T.A.4    Rubin, D.T.5
  • 65
  • 66
    • 33744551277 scopus 로고    scopus 로고
    • Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study
    • PMID: 16762617
    • Velayos FS, Loftus EV, Jess T, Harmsen W.S., Bida J., Zinsmeister AR, Tremaine WJ, Sandborn WJ. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology 2006; 130: 1941-1949 [PMID: 16762617 DOI: 10.1053/j.gastro.2006.03.028]
    • (2006) Gastroenterology , vol.130 , pp. 1941-1949
    • Velayos, F.S.1    Loftus, E.V.2    Jess, T.3    Harmsen, W.S.4    Bida, J.5    Zinsmeister, A.R.6    Tremaine, W.J.7    Sandborn, W.J.8
  • 67
    • 77954426838 scopus 로고    scopus 로고
    • Risk of cancer in inflammatory bowel disease treated with azathioprine: A UK population-based case-control study
    • PMID: 20104215
    • Armstrong RG, West J, Card TR Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study. Am J Gastroenterol 2010; 105: 1604-1609 [PMID: 20104215 DOI: 10.1038/ajg.2009.745]
    • (2010) Am J Gastroenterol , vol.105 , pp. 1604-1609
    • Armstrong, R.G.1    West, J.2    Card, T.R.3
  • 69
    • 34848893583 scopus 로고    scopus 로고
    • Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: A cohort study
    • quiz 1340-1341 PMID: 17919486
    • Gupta RB, Harpaz N, Itzkowitz S., Hossain S, Matula S, Kornbluth A., Bodian C, Ullman T. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007; 133: 1099-1105; quiz 1340-1341 [PMID: 17919486 DOI: 10.1053/j.gastro.2007.08.001]
    • (2007) Gastroenterology , vol.133 , pp. 1099-1105
    • Gupta, R.B.1    Harpaz, N.2    Itzkowitz, S.3    Hossain, S.4    Matula, S.5    Kornbluth, A.6    Bodian, C.7    Ullman, T.8
  • 70
    • 0031025741 scopus 로고    scopus 로고
    • The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis
    • [PMID: 8978339]
    • Lashner BA, Provencher KS, Seidner D.L., Knesebeck A., Brzezinski A. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 1997; 112: 29-32 [PMID: 8978339]
    • (1997) Gastroenterology , vol.112 , pp. 29-32
    • Lashner, B.A.1    Provencher, K.S.2    Seidner, D.L.3    Knesebeck, A.4    Brzezinski, A.5
  • 71
    • 84878557076 scopus 로고    scopus 로고
    • Use of azathioprine and the risk of cancer in inflammatory bowel disease
    • PMID: 23514635
    • Pasternak B, Svanström H, Schmiegelow K., Jess T, Hviid A. Use of azathioprine and the risk of cancer in inflammatory bowel disease. Am J Epidemiol 2013; 177: 1296-1305 [PMID: 23514635 DOI: 10.1093/aje/kws375]
    • (2013) Am J Epidemiol , vol.177 , pp. 1296-1305
    • Pasternak, B.1    Svanström, H.2    Schmiegelow, K.3    Jess, T.4    Hviid, A.5
  • 73
    • 33745284606 scopus 로고    scopus 로고
    • Risk factors for colorectal cancer in Crohn's colitis: A case-control study
    • [PMID: 16775493]
    • Siegel CA, Sands BE Risk factors for colorectal cancer in Crohn's colitis: a case-control study. Inflamm Bowel Dis 2006; 12: 491-496 [PMID: 16775493]
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 491-496
    • Siegel, C.A.1    Sands, B.E.2
  • 74
    • 84878222995 scopus 로고    scopus 로고
    • Is treatment with 6-mercaptopurine for colitis associated with the development of colorectal cancer?
    • PMID: 23392347
    • Satchi M, Korelitz BI, Panagopoulos G, Bratcher J., Yu C, Atallah-Vinograd J, Schneider J. Is treatment with 6-mercaptopurine for colitis associated with the development of colorectal cancer? Inflamm Bowel Dis 2013; 19: 785-788 [PMID: 23392347 DOI: 10.1097/MIB.0b013e318289664c]
    • (2013) Inflamm Bowel Dis , vol.19 , pp. 785-788
    • Satchi, M.1    Korelitz, B.I.2    Panagopoulos, G.3    Bratcher, J.4    Yu, C.5    Atallah-Vinograd, J.6    Schneider, J.7
  • 75
    • 79751528883 scopus 로고    scopus 로고
    • The risk of inflammatory bowel disease-related colorectal carcinoma is limited: Results from a nationwide nested case-control study
    • PMID: 21045815
    • Baars JE, Looman CW, Steyerberg E.W., Beukers R., Tan AC, Weusten BL, Kuipers EJ, van der Woude CJ. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol 2011; 106: 319-328 [PMID: 21045815 DOI: 10.1038/ajg.2010.428]
    • (2011) Am J Gastroenterol , vol.106 , pp. 319-328
    • Baars, J.E.1    Looman, C.W.2    Steyerberg, E.W.3    Beukers, R.4    Tan, A.C.5    Weusten, B.L.6    Kuipers, E.J.7    Van Der Woude, C.J.8
  • 76
    • 84855206195 scopus 로고    scopus 로고
    • Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease
    • PMID: 21602529
    • van Schaik F.D., van Oijen MG, Smeets HM, van der Heijden GJ, Siersema PD, Oldenburg B. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease. Gut 2012; 61: 235-240 [PMID: 21602529 DOI: 10.1136/gut.2011.237412]
    • (2012) Gut , vol.61 , pp. 235-240
    • Van Schaik, F.D.1    Van Oijen, M.G.2    Smeets, H.M.3    Van Der Heijden, G.J.4    Siersema, P.D.5    Oldenburg, B.6
  • 77
    • 0036202803 scopus 로고    scopus 로고
    • 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
    • [PMID: 11910342]
    • Dubinsky MC, Yang H, Hassard P.V., Seidman EG, Kam LY, Abreu MT, Targan S.R., Vasiliauskas EA. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology 2002; 122: 904-915 [PMID: 11910342]
    • (2002) Gastroenterology , vol.122 , pp. 904-915
    • Dubinsky, M.C.1    Yang, H.2    Hassard, P.V.3    Seidman, E.G.4    Kam, L.Y.5    Abreu, M.T.6    Targan, S.R.7    Vasiliauskas, E.A.8
  • 79
    • 0029134702 scopus 로고
    • Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis
    • [PMID: 7778826]
    • Pearson DC, May GR, Fick G.H., Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995; 123: 132-142 [PMID: 7778826]
    • (1995) Ann Intern Med , vol.123 , pp. 132-142
    • Pearson, D.C.1    May, G.R.2    Fick, G.H.3    Sutherland, L.R.4
  • 82
    • 0043011380 scopus 로고    scopus 로고
    • Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis
    • [PMID: 12960720]
    • Warman JI, Korelitz BI, Fleisher M.R., Janardhanam R. Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis. J Clin Gastroenterol 2003; 37: 220-225 [PMID: 12960720]
    • (2003) J Clin Gastroenterol , vol.37 , pp. 220-225
    • Warman, J.I.1    Korelitz, B.I.2    Fleisher, M.R.3    Janardhanam, R.4
  • 83
    • 0024457688 scopus 로고
    • 6-mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity
    • [PMID: 2802419]
    • Present DH, Meltzer SJ, Krumholz M.P., Wolke A., Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989; 111: 641-649 [PMID: 2802419]
    • (1989) Ann Intern Med , vol.111 , pp. 641-649
    • Present, D.H.1    Meltzer, S.J.2    Krumholz, M.P.3    Wolke, A.4    Korelitz, B.I.5
  • 84
    • 36549059250 scopus 로고    scopus 로고
    • Mortality by medication use among patients with inflammatory bowel disease, 1996-2003
    • PMID: 18054550
    • Hutfless SM, Weng X, Liu L., Allison J, Herrinton LJ. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003. Gastroenterology 2007; 133: 1779-1786 [PMID: 18054550 DOI: 10.1053/j.gastro.2007.09.022]
    • (2007) Gastroenterology , vol.133 , pp. 1779-1786
    • Hutfless, S.M.1    Weng, X.2    Liu, L.3    Allison, J.4    Herrinton, L.J.5
  • 88
    • 41149119335 scopus 로고    scopus 로고
    • Opportunistic infections in patients with inflammatory bowel disease: Prevention and diagnosis
    • PMID: 18178610
    • Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut 2008; 57: 549-558 [PMID: 18178610 DOI: 10.1136/gut.2006.114660]
    • (2008) Gut , vol.57 , pp. 549-558
    • Viget, N.1    Vernier-Massouille, G.2    Salmon-Ceron, D.3    Yazdanpanah, Y.4    Colombel, J.F.5
  • 89
    • 56949101640 scopus 로고    scopus 로고
    • Immune escape by Epstein-Barr virus associated Malignancies
    • PMID: 18996483
    • Münz C., Moormann A. Immune escape by Epstein-Barr virus associated malignancies. Semin Cancer Biol 2008; 18: 381-387 [PMID: 18996483 DOI: 10.1016/j.semcancer.2008.10.002]
    • (2008) Semin Cancer Biol , vol.18 , pp. 381-387
    • Münz, C.1    Moormann, A.2
  • 91
    • 33748987908 scopus 로고    scopus 로고
    • Cancer despite immuno-surveillance: Immunoselection and immunosubversion
    • PMID: 16977338
    • Zitvogel L, Tesniere A, Kroemer G. Cancer despite immuno-surveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006; 6: 715-727 [PMID: 16977338 DOI: 10.1038/nri1936]
    • (2006) Nat Rev Immunol , vol.6 , pp. 715-727
    • Zitvogel, L.1    Tesniere, A.2    Kroemer, G.3
  • 94
    • 0032754121 scopus 로고    scopus 로고
    • Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine
    • PMID: 10566724
    • Korelitz BI, Mirsky FJ, Fleisher M.R., Warman JI, Wisch N, Gleim GW. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 1999; 94: 3248-3253 [PMID: 10566724 DOI: 10.1111/j.1572-0241.1999.01530.x]
    • (1999) Am J Gastroenterol , vol.94 , pp. 3248-3253
    • Korelitz, B.I.1    Mirsky, F.J.2    Fleisher, M.R.3    Warman, J.I.4    Wisch, N.5    Gleim, G.W.6
  • 95
    • 0034764110 scopus 로고    scopus 로고
    • Inflammatory bowel disease is not associated with an increased risk of lymphoma
    • [PMID: 11677199]
    • Lewis JD, Bilker WB, Brensinger C, Deren J.J., Vaughn DJ, Strom BL. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001; 121: 1080-1087 [PMID: 11677199]
    • (2001) Gastroenterology , vol.121 , pp. 1080-1087
    • Lewis, J.D.1    Bilker, W.B.2    Brensinger, C.3    Deren, J.J.4    Vaughn, D.J.5    Strom, B.L.6
  • 96
    • 46749126662 scopus 로고    scopus 로고
    • Immune surveillance of EBV-infected B cells and the development of non-hodgkin lymphomas in immunocompromised patients
    • PMID: 18452077
    • Pietersma F, Piriou E, van Baarle D. Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients. Leuk Lymphoma 2008; 49: 1028-1041 [PMID: 18452077 DOI: 10.1080/10428190801911662]
    • (2008) Leuk Lymphoma , vol.49 , pp. 1028-1041
    • Pietersma, F.1    Piriou, E.2    Van Baarle, D.3
  • 98
    • 84866379750 scopus 로고    scopus 로고
    • Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease
    • PMID: 22241664
    • Sultan K, Korelitz BI, Present D, Katz S., Sunday S, Shapira I. Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 1855-1858 [PMID: 22241664 DOI: 10.1002/ibd.22866]
    • (2012) Inflamm Bowel Dis , vol.18 , pp. 1855-1858
    • Sultan, K.1    Korelitz, B.I.2    Present, D.3    Katz, S.4    Sunday, S.5    Shapira, I.6
  • 100
    • 84864225717 scopus 로고    scopus 로고
    • Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease
    • e1 PMID: 22584081
    • Long MD, Martin CF, Pipkin C.A., Herfarth HH, Sandler RS, Kappelman MD. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology 2012; 143: 390-399.e1 [PMID: 22584081 DOI: 10.1053/j.gastro.2012.05.004]
    • (2012) Gastroenterology , vol.143 , pp. 390-399
    • Long, M.D.1    Martin, C.F.2    Pipkin, C.A.3    Herfarth, H.H.4    Sandler, R.S.5    Kappelman, M.D.6
  • 103
    • 33747377769 scopus 로고    scopus 로고
    • Review article: Thiopurines in inflammatory bowel disease
    • PMID: 16918876
    • Derijks LJ, Gilissen LP, Hooymans P.M., Hommes DW. Review article: thiopurines in inflammatory bowel disease. Aliment Pharmacol Ther 2006; 24: 715-729 [PMID: 16918876 DOI: 10.1111/j.1365-2036.2006.02980.x]
    • (2006) Aliment Pharmacol Ther , vol.24 , pp. 715-729
    • Derijks, L.J.1    Gilissen, L.P.2    Hooymans, P.M.3    Hommes, D.W.4
  • 104
    • 0034067784 scopus 로고    scopus 로고
    • Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
    • [PMID: 10734022]
    • Dubinsky MC, Lamothe S, Yang H.Y., Targan SR, Sinnett D, Théorêt Y, Seidman EG. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118: 705-713 [PMID: 10734022]
    • (2000) Gastroenterology , vol.118 , pp. 705-713
    • Dubinsky, M.C.1    Lamothe, S.2    Yang, H.Y.3    Targan, S.R.4    Sinnett, D.5    Théorêt, Y.6    Seidman, E.G.7
  • 106
    • 0035037706 scopus 로고    scopus 로고
    • Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease
    • [PMID: 11302961]
    • Cuffari C, Hunt S, Bayless T. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Gut 2001; 48: 642-646 [PMID: 11302961]
    • (2001) Gut , vol.48 , pp. 642-646
    • Cuffari, C.1    Hunt, S.2    Bayless, T.3
  • 107
    • 34247624461 scopus 로고    scopus 로고
    • Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease
    • PMID: 17206711
    • Morales A, Salguti S, Miao C.L., Lewis JD. Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 380-385 [PMID: 17206711 DOI: 10.1002/ibd.20028]
    • (2007) Inflamm Bowel Dis , vol.13 , pp. 380-385
    • Morales, A.1    Salguti, S.2    Miao, C.L.3    Lewis, J.D.4
  • 108
    • 84864069451 scopus 로고    scopus 로고
    • The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients
    • PMID: 22664938
    • Gao X, Zhang FB, Ding L, Liu H., Wang XD, Chen BL, Bi HC, Xiao Y.L., Zhao LZ, Chen MH, Huang M, Hu PJ The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients. Eur J Gastroenterol Hepatol 2012; 24: 958-964 [PMID: 22664938 DOI: 10.1097/MEG.0b013e3283545ae3]
    • (2012) Eur J Gastroenterol Hepatol , vol.24 , pp. 958-964
    • Gao, X.1    Zhang, F.B.2    Ding, L.3    Liu, H.4    Wang, X.D.5    Chen, B.L.6    Bi, H.C.7    Xiao, Y.L.8    Zhao, L.Z.9    Chen, M.H.10    Huang, M.11    Hu, P.J.12
  • 109
    • 33646778817 scopus 로고    scopus 로고
    • 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine
    • PMID: 16633046
    • Hande S, Wilson-Rich N, Bousvaros A., Zholudev A, Maurer R, Banks P., Makrauer F, Reddy S, Burakoff R., Friedman S. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Inflamm Bowel Dis 2006; 12: 251-257 [PMID: 16633046 DOI: 10.1097/01. MIB.0000206544.05661.9f]
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 251-257
    • Hande, S.1    Wilson-Rich, N.2    Bousvaros, A.3    Zholudev, A.4    Maurer, R.5    Banks, P.6    Makrauer, F.7    Reddy, S.8    Burakoff, R.9    Friedman, S.10
  • 111
    • 24344480999 scopus 로고    scopus 로고
    • Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine
    • PMID: 16128682
    • Sparrow MP, Hande SA, Friedman S, Lim W.C., Reddy SI, Cao D, Hanauer SB. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther 2005; 22: 441-446 [PMID: 16128682 DOI: 10.1111/j.1365-2036.2005.02583.x]
    • (2005) Aliment Pharmacol Ther , vol.22 , pp. 441-446
    • Sparrow, M.P.1    Hande, S.A.2    Friedman, S.3    Lim, W.C.4    Reddy, S.I.5    Cao, D.6    Hanauer, S.B.7
  • 112
    • 76449085161 scopus 로고    scopus 로고
    • Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease
    • PMID: 20015102
    • Ansari A, Patel N, Sanderson J., O'Donohue J, Duley JA, Florin TH Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2010; 31: 640-647 [PMID: 20015102 DOI: 10.1111/j.1365-2036.2009.04221.x]
    • (2010) Aliment Pharmacol Ther , vol.31 , pp. 640-647
    • Ansari, A.1    Patel, N.2    Sanderson, J.3    O'Donohue, J.4    Duley, J.A.5    Florin, T.H.6
  • 113
    • 49149113484 scopus 로고    scopus 로고
    • Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease
    • [PMID: 21960930]
    • Sparrow MP. Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2008; 4: 505-511 [PMID: 21960930]
    • (2008) Gastroenterol Hepatol (N Y) , vol.4 , pp. 505-511
    • Sparrow, M.P.1
  • 114
    • 84981275794 scopus 로고    scopus 로고
    • Randomized clinical trial: A pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel disease
    • PMID: 27686002
    • Kiszka-Kanowitz M., Theede K, Mertz-Nielsen A. Randomized clinical trial: a pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel disease. Scand J Gastroenterol 2016; 51: 1470-1475 [PMID: 27686002 DOI: 10.1080/00365521.2016. 1216589]
    • (2016) Scand J Gastroenterol , vol.51 , pp. 1470-1475
    • Kiszka-Kanowitz, M.1    Theede, K.2    Mertz-Nielsen, A.3
  • 115
    • 84976324424 scopus 로고    scopus 로고
    • Long-term safety and efficacy of low-dose azathioprine and allopurinol cotherapy in inflammatory bowel disease: A large observational study
    • PMID: 27271488
    • Pavlidis P, Stamoulos P, Abdulrehman A., Kerr P, Bull C, Duley J., Ansari A. Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study. Inflamm Bowel Dis 2016; 22: 1639-1646 [PMID: 27271488 DOI: 10.1097/MIB.0000000000000827]
    • (2016) Inflamm Bowel Dis , vol.22 , pp. 1639-1646
    • Pavlidis, P.1    Stamoulos, P.2    Abdulrehman, A.3    Kerr, P.4    Bull, C.5    Duley, J.6    Ansari, A.7
  • 116
  • 120
    • 34548130215 scopus 로고    scopus 로고
    • Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease
    • PMID: 17229796
    • Vermeire S, Noman M, Van Assche G, Baert F, D'Haens G, Rutgeerts P. Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease. Gut 2007; 56: 1226-1231 [PMID: 17229796 DOI: 10.1136/gut.2006.099978]
    • (2007) Gut , vol.56 , pp. 1226-1231
    • Vermeire, S.1    Noman, M.2    Van Assche, G.3    Baert, F.4    D'Haens, G.5    Rutgeerts, P.6
  • 122
    • 84875875397 scopus 로고    scopus 로고
    • Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab?
    • PMID: 23061650
    • Reenaers C, Louis E, Belaiche J., Seidel L, Keshav S, Travis S. Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab? Aliment Pharmacol Ther 2012; 36: 1040-1048 [PMID: 23061650 DOI: 10.1111/apt.12076]
    • (2012) Aliment Pharmacol Ther , vol.36 , pp. 1040-1048
    • Reenaers, C.1    Louis, E.2    Belaiche, J.3    Seidel, L.4    Keshav, S.5    Travis, S.6
  • 124
    • 84945247207 scopus 로고    scopus 로고
    • Efficacy of sustained combination therapy for at least 6 months with thiopurines and infliximab in patients with ulcerative colitis in clinical remission: A retrospective multicenter French experience
    • PMID: 25588386
    • Filippi J, Laharie D, Michiels C., Flamand M, Bouguen G, Nancey S., Presles E, Paul S, Schneider S., Hébuterne X, Roblin X. Efficacy of sustained combination therapy for at least 6 months with thiopurines and infliximab in patients with ulcerative colitis in clinical remission: a retrospective multicenter French experience. J Crohns Colitis 2015; 9: 252-258 [PMID: 25588386 DOI: 10.1093/ ecco-jcc/jjv001]
    • (2015) J Crohns Colitis , vol.9 , pp. 252-258
    • Filippi, J.1    Laharie, D.2    Michiels, C.3    Flamand, M.4    Bouguen, G.5    Nancey, S.6    Presles, E.7    Paul, S.8    Schneider, S.9    Hébuterne, X.10    Roblin, X.11
  • 126
    • 84878237639 scopus 로고    scopus 로고
    • Expert opinion: Experience with 6-mercaptopurine in the treatment of inflammatory bowel disease
    • PMID: 23716977
    • Korelitz BI. Expert opinion: experience with 6-mercaptopurine in the treatment of inflammatory bowel disease. World J Gastroenterol 2013; 19: 2979-2984 [PMID: 23716977 DOI: 10.3748/wjg.v19.i20.2979]
    • (2013) World J Gastroenterol , vol.19 , pp. 2979-2984
    • Korelitz, B.I.1
  • 127
    • 84904459830 scopus 로고    scopus 로고
    • 6-mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease
    • PMID: 24462321
    • Korelitz BI, Present DH 6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease. J Crohns Colitis 2014; 8: 735-738 [PMID: 24462321 DOI: 10.1016/j.crohns.2013.12.024]
    • (2014) J Crohns Colitis , vol.8 , pp. 735-738
    • Korelitz, B.I.1    Present, D.H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.